High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence

Published:2020-01-08 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Carretero-Iglesia Laura,Couturaud Barbara,Baumgaertner Petra,Schmidt Julien,Maby-El Hajjami Hélène,Speiser Daniel E.,Hebeisen Michael,Rufer Nathalie

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference61 articles.

1. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells;Carreno;Science.,2015

2. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer;Sahin;Nature.,2017

3. Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer;Tanyi;Sci Transl Med.,2018

4. The Human Vaccines Project: a roadmap for cancer vaccine development;Romero;Sci Transl Med.,2016

5. Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909;Speiser;J Clin Invest.,2005

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of the Anti-Viral and Vaccine-Specific CD8+ T Cell Composition upon Treatment with the Cancer Vaccine VSV-GP;Vaccines;2024-08-01

2. Immunogenicity of Non-Mutated Ovarian Cancer-Specific Antigens;Current Oncology;2024-05-30

3. Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma;Journal for ImmunoTherapy of Cancer;2024-05

4. Overall avidity declines in TCR repertoires during latent CMV but not EBV infection;Frontiers in Immunology;2023-11-20

5. Characteristics of clinical trials for non-small cell lung cancer therapeutic vaccines registered on ClinicalTrials.gov;Frontiers in Immunology;2022-10-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3